Research investigator will also treat kidney patients

FOR IMMEDIATE RELEASE:

DANVILLE, PA -- Nephrologist Kevin Ho, M.D. (right), has joined Geisinger as a research investigator in the Geisinger Kidney Health Research Institute and as a kidney disease specialist, treating patients at Geisinger Medical Center in Danville.

Dr. Ho studies kidney disease at a molecular level and is interested in combining patient medical histories with detailed genomic data — becoming available through the MyCode Community Health Initiative — to identify the particular molecular pathways affected in subgroups of kidney disease patients to better target individualized treatments to patients.

Dr. Ho said he was excited to join Geisinger, both to treat patients and to pursue his research interests.

“Geisinger is ideally suited for this research work given its well-developed focus on personalized medicine and translational science as illustrated by its commitment to bioinformatics and genomic medicine,” Dr. Ho said.

Dr. Ho joins Geisinger from the University of Pittsburgh School of Medicine, where he served as an associate professor of medicine in the school’s renal-electrolyte division and its Clinical and Translational Science Institute.

A native of Cleveland, Ohio, Dr. Ho received his undergraduate degree in biological sciences from Harvard University in 1982 and his doctor of medicine degree from Columbia University in New York in 1987.

“We are pleased to have Dr. Ho join our team here at the Geisinger nephrology department and believe his experience in the care of patients with kidney disease will be a significant asset to our patients,” said Evan R. Norfolk, M.D., director of the nephrology department.

 

About Geisinger 
Geisinger is an integrated health services organization widely recognized for its innovative use of the electronic health record and the development of innovative care delivery models such as ProvenHealth Navigator®, ProvenCare® and ProvenExperience®. As one of the nation’s largest health service organizations, Geisinger serves more than 3 million residents throughout 45 counties in central, south-central and northeast Pennsylvania, and also in southern New Jersey at AtlantiCare, a Malcolm Baldrige National Quality Award recipient. In 2017, the Geisinger Commonwealth School of Medicine and Geisinger Jersey Shore Hospital became the newest members of the Geisinger Family. The physician-led system is comprised of approximately 30,000 employees, including nearly 1,600 employed physicians, 13 hospital campuses, two research centers, and a 583,000-member health plan, all of which leverage an estimated $12.7 billion positive impact on the Pennsylvania and New Jersey economies. Geisinger has repeatedly garnered national accolades for integration, quality and service. In addition to fulfilling its patient care mission, Geisinger has a long-standing commitment to medical education, research and community service. For more information, visit Geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.

For media inquiries:

Corporate Communications
570-808-5813